PMH Capital

IXICO posts 26% revenue growth and stronger margins in H1 2025, breakthroughs in neuroimaging analytics

IXICO announces 26% LFL sales growth, stronger margins and balance sheet, and key milestones in neuroimaging innovation in H1 2025, reinforcing its momentum in neurological drug development.

Venture Life Group shares soar on €62m disposal of CDMO assets

9 days ago

Venture Life Group divests its contract development and manufacturing operations (CDMO) and non-core products for €62m to Italy-based BioDue SpA, to streamline operations and accelerate growth in its core healthcare brands.

Eleco delivers record 2024 results: double-digit growth in revenue, profit, and dividends

20 days ago

Eleco posted stellar FY24 performance, surpassing market expectations with 16% revenue growth, 24% higher profitability, and record recurring revenue, driving strong cashflow and dividend increases.

Mpac Group reports FY24 results: record revenue, strong orderbook, positive FY25 outlook

22 days ago

Mpac Group delivers strong FY24 performance in line with expectations, with record revenue, enhanced margins, and a robust orderbook, positioning for continued growth in FY25

Finseta posts 26% revenue growth in FY24, expands product portfolio and global footprint

28 days ago

Finseta reported a 26% increase in revenue for FY24, driven by growth in active customers, new product launches eg the corporate card and mass payments, and expanded operations in Canada and the UAE.

Supreme delivers record £235m revenue in FY25, boosted by acquisitions

28 days ago

Supreme posts record FY25 revenue of £235m, fueled by strategic acquisitions, cost management, and solid growth in new and existing markets.

Belluscura reports strong Q1 growth, X-PLOR 5 launch, and CFO transition

1 month ago

Belluscura reports a significant increase in Q1 sales to $912k, launches the X-PLOR 5 portable oxygen concentrator, and announces the resignation of CFO Simon Neicheril, effective May 2, 2025.

IXICO delivers strong H1 2025 with 26% revenue growth and expanded US operations

1 month ago

IXICO reports a 26% revenue increase to £3.2m, a strengthened cash position, and strategic advancements in Alzheimer's and Parkinson's research during H1 2025.

Verici Dx receives Medicare coverage for Tutivia, shares soar

1 month ago

Verici Dx has secured Medicare coverage for its Tutivia assay, a diagnostic tool for detecting acute rejection in kidney transplant patients, supporting broader patient access and clinical adoption.

Belluscura navigates trade tariff headwinds, revises FY25 outlook

1 month ago

Belluscura has withdrawn its FY25 guidance in response to US-China tariff tensions but remains well-positioned to navigate the challenges with strong leadership and ample capital.

Verici Dx sees 68% Q1 growth in Tutivia test orders, Medicare coverage decision imminent

1 month ago

Verici Dx reported a 68% increase in Tutivia test orders in Q1 2025, with growth expected to continue pending an upcoming decision on Medicare coverage.

US tariff crisis: short-term weakness, but a potential bounce ahead

1 month ago

As US tariffs create short-term market volatility, investors may see a bounce in the coming months as distressed selling eases and strategic trade deals unfold.

Directors back Argentex after strong FY24 results, CEO Ormonde invests £150k amid growth plans

2 months ago

Five directors, including CEO Jim Ormonde, have made substantial investments in Argentex following the group's positive FY24 results, as it prepares to launch new services aimed at expanding its forex and treasury solutions.

US markets sink as tariff shock hits growth and inflation outlook

2 months ago

US stocks plunge following Trump’s tariff announcement, as investors brace for potential economic fallout on American GDP, inflation, and corporate earnings.

Argentex outperforms profit expectations, advances global expansion plans

2 months ago

Argentex reported stronger-than-expected profit margins and 2H24 revenue growth, with global expansion and digital service launches set to drive further growth in FY25.

Big Technologies dismisses CEO, delays full-year results, trading remains strong

2 months ago

Big Technologies has dismissed its CEO and initiated legal action, but strong cashflow, a new £20m contract, and solid financials position the company for continued growth.

Finseta secures licence to expand payment services in UAE

2 months ago

Finseta has been granted a Category 3D licence by the Dubai Financial Services Authority, allowing it to expand its payment services within the UAE.

CAPD - Profit warning & CEO walks the plank

2 months ago

Capital Ltd - a provider of drilling, mining, maintenance and geochemical laboratory solutions for the mining industry (eg gold & copper in US & Africa) said today that it "expects 2024 net profit after tax to be in the range of $18m-$20m"

Atlanta Fed’s GDPNow forecast plummets: Is the US economy stalling?

3 months ago

The collapse in the Atlanta Fed's Q1 GDPNow forecast points to a sharp deceleration in US economic momentum amid recent policy and trade shifts.

Finseta launches corporate Mastercard to drive business market expansion

3 months ago

Finseta has launched a new Corporate Card to expand its business market reach and enhance its multi-currency offering to enterprise customers globally.

Watchlist